2016
DOI: 10.5582/irdr.2016.01037
|View full text |Cite
|
Sign up to set email alerts
|

The Government's role in regulating, coordinating, and standardizing the response to Alzheimer's disease: Anticipated international cooperation in the area of intractable and rare diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 18 publications
(11 reference statements)
0
3
0
Order By: Relevance
“…Alzheimer's disease (AD) is the primary dementia‐causing disease and approximately 46.8 million people worldwide had dementia in 2015 . It is estimated that 5–7% of older adults who are 60 years and over will be affected by AD . The most common early symptom in AD is difficulty in remembering recently learned information.…”
Section: The Amyloid Precursor Protein (App) and The Production Of Aβmentioning
confidence: 99%
“…Alzheimer's disease (AD) is the primary dementia‐causing disease and approximately 46.8 million people worldwide had dementia in 2015 . It is estimated that 5–7% of older adults who are 60 years and over will be affected by AD . The most common early symptom in AD is difficulty in remembering recently learned information.…”
Section: The Amyloid Precursor Protein (App) and The Production Of Aβmentioning
confidence: 99%
“…For imported orphan drugs, further promote the use of real-world research, an orphan drug import tariff reduction system and a free public platform for all stakeholders to share information on orphan drugs also need to be developed. International cooperation will play a crucial role in the response to rare diseases [ 33 ]. Besides, the high market accessibility rare diseases (endocrine, nutritional and metabolic diseases, etc.)…”
Section: Discussionmentioning
confidence: 99%
“…rare diseases make these diseases a priority for policymakers, researchers, legislators, and healthcare professionals (4,5).…”
mentioning
confidence: 99%